Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00903994 · ClinicalTrials.gov registry record · Phase 2
A Pilot Study on the Onset of Action of KTP, 20% in the Treatment of Acute Pain Associated With Tendonitis or Bursitis of the Shoulder, Elbow or Knee
A Phase 2 study, sponsored by APR Applied Pharma Research s.a..
- Completed
- Registry status
- Phase 2
- Development phase
- 17
- Enrollment target
NCT00903994 is a Phase 2 study that has completed, run by APR Applied Pharma Research s.a.. The registered enrollment target is 17 participants.
The verdict
NCT00903994, a Phase 2 study, has completed, sponsored by APR Applied Pharma Research s.a..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 17 participants
- Enrollment target
Study Summary
Open-label study to be conducted at 2 US investigational sites in subjects who have acute tendonitis or bursitis of the shoulder, elbow, or knee. Eligible subjects receive treatment with the KTP, applied once daily at the same application site for 3 consecutive days.
Interventions
- DRUG Ketoprofen Topical Patch 20%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2007-06 |
| Est. Completion | 2007-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00903994
The ClinicalTrials.gov registry entry for NCT00903994 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is APR Applied Pharma Research s.a., which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketoprofen Topical Patch 20% is the first listed.
NCT00903994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00903994 about?
NCT00903994 is a clinical study titled "A Pilot Study on the Onset of Action of KTP, 20% in the Treatment of Acute Pain Associated With Tendonitis or Bursitis of the Shoulder, Elbow or Knee". Open-label study to be conducted at 2 US investigational sites in subjects who have acute tendonitis or bursitis of the shoulder, elbow, or knee. Eligible subjects receive treatment with the KTP, applied once daily at the same application site for 3 consecutive days.
What is the current status of trial NCT00903994?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 17 participants. The study started on 2007-06. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00903994?
The interventions under investigation include: Ketoprofen Topical Patch 20% (DRUG).
Who is sponsoring clinical trial NCT00903994?
This trial is sponsored by APR Applied Pharma Research s.a., which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.